Joanna Wiensch
Stock Analyst at Citigroup
(2.38)
# 2,288
Out of 5,182 analysts
32
Total ratings
65.22%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $232 → $198 | $149.43 | +32.50% | 9 | Feb 11, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $84.32 | +50.62% | 8 | Aug 22, 2024 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $60.61 | +48.90% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $60.00 | +32.50% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Holdings | Initiates: Buy | $120 | $120.66 | -0.55% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $322.23 | -37.93% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $133.52 | -70.04% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $82.33 | +104.06% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $62.56 | +0.70% | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | $235 | $285.47 | -17.68% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $154.16 | +42.71% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $79.96 | +5.05% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $17.99 | +422.51% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $221.32 | -26.35% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $76.15 | +62.84% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Feb 11, 2026
Maintains: Buy
Price Target: $232 → $198
Current: $149.43
Upside: +32.50%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $84.32
Upside: +50.62%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $60.61
Upside: +48.90%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $60.00
Upside: +32.50%
iRhythm Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $120.66
Upside: -0.55%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $322.23
Upside: -37.93%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $133.52
Upside: -70.04%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $82.33
Upside: +104.06%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $62.56
Upside: +0.70%
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $285.47
Upside: -17.68%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $154.16
Upside: +42.71%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $79.96
Upside: +5.05%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $17.99
Upside: +422.51%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $221.32
Upside: -26.35%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $76.15
Upside: +62.84%